Why does JP Morgan have an underweight rating on Wesfarmers shares?

Read on to find out what's behind the rating.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Wesfarmers has demonstrated strong performance, with shares up over 100% in five years, but JP Morgan rates them underweight due to what it sees as an excessive valuation.
  • Although Bunnings and Kmart drive earnings growth, Wesfarmers trades at a high 36x earnings, and JP Morgan sets a price target of $73.00.
  • The company may see potential gains if macroeconomic conditions improve, particularly with interest rate cuts expected.

Wesfarmers Ltd (ASX: WES) shares are very popular amongst ASX investors. 

Wesfarmers is one of Australia's largest and most well-known retailers, with brands like Kmart, Bunnings, Officeworks, and Target in its portfolio.

These are places that everyday Australians shop at and see doing well. Many of these stores are often packed with customers, especially around the holiday season.

It's therefore understandable that many Australians may see Wesfarmers shares as a solid investment. 

That perception is also backed by Wesfarmers shares' long-term track record. The company is up more than 100% over the past 5 years, not including dividends paid along the way. Wesfarmers currently offers a moderate dividend yield of 2.24%. 

That kind of return is high enough to please just about any investor. 

But what does the future look like? According to JP Morgan Chase & Co (NYSE: JPM), it is not as appealing

Last month, the investment bank released a research note on Wesfarmers shares, rating the stock as underweight. 

Let's find out what was behind this rating.

A group of stockbrokers sit in a room with several computer screens in front of them as they discuss the Zip share price and Zip's merger with Sezzle

Image source: Getty Images

All about the valuation

In its 27 August research note, JP Morgan commended Wesfarmers for delivering a high-quality FY25 result and solid trading update. 

JP Morgan said Bunnings and Kmart continue to deliver earnings growth, underpinning mid-single digit group earnings per share (EPS), a strong balance sheet, and cash flow generation.

The investment bank said this reinforced its premium valuation. Wesfarmers shares currently trade at around 36 times earnings

Commenting on its rating and price target, JP Morgan said:

We continue to see this valuation as excessive, but also fail to see any catalysts to drive a de-rate back to what we consider a fair multiple (~27x PER at our $73.00 target price). If Bunnings and Kmart continue to deliver mid to high single digit growth (which we expect), Wesfarmers is likely to remain well held in what has been a highly volatile market backdrop. Following minor EPS revisions (-0.4% in FY26 and -0.2% in FY27) we increase our price target from $70.00 to $73.00, maintaining our Underweight rating.

Keep an eye on the macro

As a consumer discretionary business, Wesfarmers shares are economically sensitive. 

JP Morgan also acknowledged that a rebound in discretionary spending due to an improved macroeconomic outlook, including the outlook for housing, could result in positive upside. 

With further interest rate cuts projected this year, it's possible that Wesfarmers shares could benefit.

Today's interest rate decision by the Reserve Bank of Australia (RBA) could provide insight into the likely future pathway for rate cuts for the remainder of 2025.

JPMorgan Chase is an advertising partner of Motley Fool Money. Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended JPMorgan Chase and Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Smiling couple sitting on a couch with laptops fist pump each other.
Broker Notes

Buy, hold, sell: Beach Energy, Flight Centre, and Judo Capital shares

Does Morgans rate these shares as buys? Let's find out.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy right now

Let's find out which shares top brokers are feeling bullish about this week.

Read more »

A smug executive woman wearing glasses and red lipstick blows a kiss to herself as she takes a selfie.
Broker Notes

6 ASX shares with upgraded ratings from experts this week

Brokers have flagged new confidence in Flight Centre, Iluka Resources, and other ASX shares.

Read more »

A group of people jump for joy and dance around celebrating good news.
Broker Notes

8 ASX 200 shares with reaffirmed buy recommendations this week

Judo Bank, which dove 46% yesterday, is among the ASX 200 shares with reiterated buy ratings this week.

Read more »

Man holding Australian dollar notes, symbolising dividends.
Broker Notes

Should you buy this ASX 200 share for its 15% forecast dividend yield?

Bell Potter is bullish on this stock. Let's find out why.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Is this exciting ASX tech stock a buy after its massive news?

This tech stock has been the talk of the town this week.

Read more »

Woman checking out new laptops.
Broker Notes

3 reasons to buy the rebound in JB Hi-Fi shares today

A leading analyst suggests JB Hi-Fi shares are well-placed to outperform. But why?

Read more »

Broker looking at the share price on her laptop with green and red points in the background.
Broker Notes

Buy, hold, sell: Capricorn Metals, Chrysos, Cochlear shares

Analysts reveal their views on this gold miner, tech solutions provider, and healthcare share.

Read more »